 adjuv specif activ immunotherapi resect squamou cell lung carcinoma surviv analysi stewart al new york academi scienc effect adjuv specif activ immunotherapi lung carcinoma postop surviv stage carcinoma patient phase II studi lung carcinoma-associ antigen taa complet freund adjuv cfa phase iii studi author effect specif activ immunotherapi convent manag treatment nonspecif immunotherapi patient resect stage II squamou cell lung carcinoma random studi control group specif immunotherapi group monthli dose microgram taa cfa nonspecif immunotherapi group monthli dose cfa salin patient studi skin test microgram taa immunotherapi follow-up patient avail life tabl surviv group group group median surviv group group month group month group month differ signific cox-mantel test